Poseida Therapeutics Inc (PSTX)
3.19
-0.16
(-4.63%)
USD |
NASDAQ |
May 17, 16:00
3.19
0.00 (0.00%)
After-Hours: 20:00
Poseida Therapeutics Free Cash Flow (Quarterly): -15.26M for March 31, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -15.26M |
December 31, 2023 | -29.05M |
September 30, 2023 | 7.099M |
June 30, 2023 | -34.49M |
March 31, 2023 | -38.79M |
December 31, 2022 | 2.143M |
September 30, 2022 | 60.18M |
June 30, 2022 | -40.95M |
March 31, 2022 | -52.07M |
December 31, 2021 | 8.26M |
September 30, 2021 | -41.24M |
Date | Value |
---|---|
June 30, 2021 | -32.67M |
March 31, 2021 | -39.53M |
December 31, 2020 | -32.47M |
September 30, 2020 | -32.13M |
June 30, 2020 | -39.24M |
March 31, 2020 | -26.40M |
December 31, 2019 | -17.95M |
September 30, 2019 | -20.99M |
June 30, 2019 | -15.81M |
March 31, 2019 | -14.93M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-52.07M
Minimum
Mar 2022
60.18M
Maximum
Sep 2022
-21.57M
Average
-30.59M
Median
Free Cash Flow (Quarterly) Benchmarks
Biomea Fusion Inc | -32.06M |
Cartesian Therapeutics Inc | -16.52M |
Lantern Pharma Inc | -3.071M |
NovaBay Pharmaceuticals Inc | -1.574M |
Palatin Technologies Inc | -8.607M |